FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078744527> ?p ?o ?g. }

• W2078744527 endingPage "226" @default.
• W2078744527 startingPage "218" @default.
• W2078744527 abstract "Annals of the New York Academy of SciencesVolume 524, Issue 1 p. 218-226 Immune Regulation by Leukotriene B4a MAREK ROLA-PLESZCZYNSKI, MAREK ROLA-PLESZCZYNSKI Immunology Division, Department of Pediatrics, Faculty of Medicine, University of Sherbrooke, Sherbrooke, Quebec, Canada J1H 5N4 M. Rola-Pleszczynski is a Research Scholar of the Fonds de la Recherche en Santé du Québec. L. Gagnon is a recipient of a studentship from the Institut de Recherche en Santé et Sécurité au Travail.Search for more papers by this authorLYNE GAGNON, LYNE GAGNON Immunology Division, Department of Pediatrics, Faculty of Medicine, University of Sherbrooke, Sherbrooke, Quebec, Canada J1H 5N4 M. Rola-Pleszczynski is a Research Scholar of the Fonds de la Recherche en Santé du Québec. L. Gagnon is a recipient of a studentship from the Institut de Recherche en Santé et Sécurité au Travail.Search for more papers by this authorPIERRE-ANDRÉ CHAVAILLAZ, PIERRE-ANDRÉ CHAVAILLAZ Immunology Division, Department of Pediatrics, Faculty of Medicine, University of Sherbrooke, Sherbrooke, Quebec, Canada J1H 5N4 P-A. Chavaillaz was a postdoctoral fellow of the Swiss Science Foundation. Current address: University of Bern, Bern, Switzerland.Search for more papers by this author MAREK ROLA-PLESZCZYNSKI, MAREK ROLA-PLESZCZYNSKI Immunology Division, Department of Pediatrics, Faculty of Medicine, University of Sherbrooke, Sherbrooke, Quebec, Canada J1H 5N4 M. Rola-Pleszczynski is a Research Scholar of the Fonds de la Recherche en Santé du Québec. L. Gagnon is a recipient of a studentship from the Institut de Recherche en Santé et Sécurité au Travail.Search for more papers by this authorLYNE GAGNON, LYNE GAGNON Immunology Division, Department of Pediatrics, Faculty of Medicine, University of Sherbrooke, Sherbrooke, Quebec, Canada J1H 5N4 M. Rola-Pleszczynski is a Research Scholar of the Fonds de la Recherche en Santé du Québec. L. Gagnon is a recipient of a studentship from the Institut de Recherche en Santé et Sécurité au Travail.Search for more papers by this authorPIERRE-ANDRÉ CHAVAILLAZ, PIERRE-ANDRÉ CHAVAILLAZ Immunology Division, Department of Pediatrics, Faculty of Medicine, University of Sherbrooke, Sherbrooke, Quebec, Canada J1H 5N4 P-A. Chavaillaz was a postdoctoral fellow of the Swiss Science Foundation. Current address: University of Bern, Bern, Switzerland.Search for more papers by this author First published: April 1988 https://doi.org/10.1111/j.1749-6632.1988.tb38545.xCitations: 22 a This work was supported by grants from the Medical Research Council of Canada and the National Cancer Institute. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Samuelsson, B., P. Borgeat, S. Hammarström & R. C. Murphy. 1979. Introduction of a nomenclature: leukotrienes. Prostaglandins 17: 785–787. 2 Borgeat, P. & B. Samuelsson. 1979. Metabolism of arachidonic acid in polymorphonu-clear leukocytes: effect of the ionophore A23187. Proc. Natl. Acad. Sci. USA 76: 2148–2152. 3 Borgeat, P. & B. Samuelsson. 1979. Metabolism of arachidonic acid in polymorphonuclear leukocytes. Structural analysis of novel hydroxylated compounds. J. Biol. Chem. 254: 7865–7869. 4 Ford-Hutchinson, A. W., M. A. Bray, M. V. Doig, M. E. Shipley & M. J. Smith. 1980. Leukotriene B, a potent chemokinetic and aggregating substance released from polymor-phonuclear leukocytes. Nature 286: 264–265. 5 Showell, H. J., P. H. Naccache, P. Borgeat, S. Picard, P. Valerand, E. L. Becker & R. I. Sha'afi. 1982. Characterization of the secretory activity of LTB4 toward rabbit neutrophils. J. Immunol. 128: 811–816. 6 Molski, T. F. P., P. H. Naccache, P. Borgeat & R. I. Sha'afi. 1981. Similarities in the mechanisms by which formylmethionyl-leucyl-phenylalamine, arachidonic acid and leukotriene B4 increase calcium and sodium influxes in rabbit neutrophils. Biochem. Biophys. Res. Commun. 103: 227–232. 7 Bray, M. A., F. M. Cunningham, A. W. Ford-Hutchinson & M. J. H. Smith. 1981. Leukotriene B4: a mediator of vascular permeability. Br. J. Pharmacol. 72: 483–486. 8 Bray, M. A., A. W. Ford-Hutchinson & M. J. H. Smith. 1981. Leukotriene B4: an inflammatory mediator in vivo. Prostaglandins 22: 213–222. 9 Fels, A. O., N. A. Pawlowski, E. B. Cramer, T. K. King, Z. A. Cohen & W. A. Scott. 1982. Human alveolar macrophages produce leukotriene B4. Proc. Natl. Acad. Sci. USA 79: 7866–7870. 10 Brain, S. D., R. D. R. Camp, P. M. Dowd, A. K. Black, P. M. Woollard, A. I. Mallet & M. W. Greaves. 1982. Psoriasis and leukotriene B4. Lancet 2: 762–763. 11 Goldyne, M. E. & J. D. Stobo. 1982. Human monocytes synthesize eicosanoids from T lymphocyte-derived arachidonic acid. Prostaglandins 24: 623–630. 12 Sharon, P. & W. F. Stenson. 1983. Production of leukotrienes by colonic mucosa from patients with inflammatory blood disease. Gastroenterology 84: 1306(A). 13 Goetzl, E. J., D. G. Payan & D. W. Goldman. 1984. Immunopathogenetic roles of leukotrienes in human diseases. J. Clin. Immunol. 4: 79–84. 14 Rola-Pleszczynski, M. 1985. Immunoregulation by leukotrienes and other lipoxygenase metabolites. Immunol. Today 6: 302–307. 15 Gagnon, L., M. Girard, A. K. Sullivan & M. Rola-Pleszczynski. 1987. Augmentation of human natural cytotoxic cell activity by leukotriene B4 mediated by enhanced effector-target cell binding and increased lytic efficiency. Cell. Immunol. 16 Rola-Pleszczynski, M., L. Gagnon, M. Rudzinska, P. Borgeat & P. Sirois. 1984. Human natural cytotoxic cell activity: enhancement by leukotrienes (LT) A4, B4 and D4 but not stereoisomers of LTB4 or HETEs. Prostaglandins Leukotrienes Med. 13: 113–117. 17 Rola-Pleszczynski, M., L. Gagnon & P. Sirois. 1983. Leukotriene B4 augments human natural cytotoxic cell activity. Biochem. Biophys. Res. Commun. 113: 531–537. 18 Rola-Pleszczynski, M., L. Gagnon & P. Sirois. 1984. Natural cytotoxic cell activity enhanced by leukotriene B4: modulation by cyclooxygenase and lipoxygenase inhibitors. In Icosanoids and Cancer. H. Thaler-Dao, Ed.: 235–242. Raven Press. New York . 19 Rola-Pleszczynski, M., P. Borgeat & P. Sirois. 1982. Leukotriene B4 induces human suppressor lymphocytes. Biochem. Biophys. Res. Commun. 108: 1531–1537. 20 Rola-Pleszczynski, M. 1985. Differential effects of leukotriene B4 on T4+ and T8+ lymphocyte phenotype and immunoregulatory functions. J. Immunol. 135: 1357–1360. 21 Rola-Pleszczynski, M., L. Gagnon, V. Radoux, C. Pouliot & E. J. Corey. 1985. Differential effects of leukotriene B4 and its analogs on suppressor and helper cell function. In Prostaglandins, Leukotrienes and Lipoxins: Biochemistry, Mechanism of Action and Clinical Applications. J. M. Bailey, Ed.: 547–553. Plenum. New York . 22 Rola-Pleszczynski, M. 1980. In vitro induction of human cell-mediated cytotoxicity directed against herpes simplex virus-infected cells: characterization of the effector lymphocyte. J. Immunol. 125: 1475–1480. 23 Rola-Pleszczynski, M., H. Lieu, A. K. Sullivan & M. Girard. 1985. Membrane markers, target cell specificity, and sensitivity to biological response modifiers distinguish human natural cytotoxic from human natural killer cells. J. Clin. Invest. 76: 1927–1931. 24 Gillis, S., M. M. Ferm, W. Ou & K. A. Smith. 1978. Tcell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120: 2027–2032. 25 Guttery, J. E., A. Tilden, D. K. Herron, P. Gallagher, S. R. Baker & A. W. Ades. 1984. Leukotrienes (LTB4 and LTD4): in vitro effects on human lymphocyte proliferation and transformation. J. Clin. Lab. Immunol. 13: 151–153. 26 Atluru, D. & J. S. Goodwin. 1984. Control of polyclonal immunoglobulin production from human lymphocytes by leukotrienes: leukotriene B4 induces an OKT8+, radiosensitive suppressor cell from resting human OKT8- T cells. J. Clin. Invest. 74: 1444–1450. 27 Payan, D. G. & E. J. Goetzl. 1983. Specific suppression of human lymphocyte function by leukotriene B4. J. Immunol. 131: 551–553. 28 Gualde, N., D. Atluru & J. S. Goodwin. 1985. Effect of lipoxygenase metabolites of arachidonic acid on proliferation of human T cells and T cell subsets. J. Immunol. 134: 1125–1129. 29 Payan, D. G., A. Missirian-Bastian & E. J. Goetzl. 1984. Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B4. Proc. Natl. Acad. Sci. USA 81: 3501–3503. 30 Rola-Pleszczynski, M. & P. Sirois. 1983. Leukotrienes as immunoregulators. In Leukotrienes and Other Lipoxygenase Products. P. J. Piper, Ed.: 234–240. Wiley. New York . 31 Rola-Pleszczynski, M. & I. Lemaire. 1985. Leukotrienes augment interleukin 1 production by human monocytes. J. Immunol. 135: 3958–3960. 32 Dinarello, C. A., I. Bishai, L. J. Rosenwasser & F. Coceani. 1984. The influence of lipoxygenase inhibitors on the in vitro production of human leukocytic pyrogen and lymphocyte activating factor (interleukin-1). Int. Immunopharmacol. 1: 43–50. 33 Rola-Pleszczynski, M., L. Bouvrette, D. Gingras & M. Girard. 1987. Identification of interferon-γ as the lymphokine which mediates leukotriene B4-induced immunoregula-tion. J. Immunol. 139. 34 Rola-Pleszczynski, M., P-A. Chavaillaz & I. Lemaire. 1986. Stimulation of interleukin 2 and interferon gamma production by leukotriene B4 in human lymphocyte cultures. Prostaglandins Leukotrienes Med. 23: 207–210. 35 Mexmain, S., J. Cook, J-C. Aldigier, N. Gualde & M. Rigaud. 1985. Thymocyte cyclic AMP and cyclic GMP response to treatment with metabolites issued from the lipoxygenase pathway. J. Immunol. 135: 1361–1365. 36 Gagnon, L., L. Fillion & M. Rola-Pleszczynski. 1987. Leukotriene B4 augments tumor necrosis factor production by human monocytes. Fed. Proc. Fed. Am. Soc. Exp. Biol. 46: 6253. Citing Literature Volume524, Issue1Biology of the LeukotrienesApril 1988Pages 218-226 ReferencesRelatedInformation" @default.
• W2078744527 created "2016-06-24" @default.
• W2078744527 creator A5061708161 @default.
• W2078744527 creator A5064945180 @default.
• W2078744527 creator A5082695286 @default.
• W2078744527 date "1988-04-01" @default.
• W2078744527 modified "2023-10-14" @default.
• W2078744527 title "Immune Regulation by Leukotriene B₄" @default.
• W2078744527 cites W1147044760 @default.
• W2078744527 cites W1480708545 @default.
• W2078744527 cites W1506157243 @default.
• W2078744527 cites W1552275448 @default.
• W2078744527 cites W1583671290 @default.
• W2078744527 cites W1601627056 @default.
• W2078744527 cites W1814307426 @default.
• W2078744527 cites W1896640126 @default.
• W2078744527 cites W1908466452 @default.
• W2078744527 cites W1975832104 @default.
• W2078744527 cites W1983217455 @default.
• W2078744527 cites W1983441105 @default.
• W2078744527 cites W1993725936 @default.
• W2078744527 cites W1996191602 @default.
• W2078744527 cites W2016296153 @default.
• W2078744527 cites W2018577520 @default.
• W2078744527 cites W2023213942 @default.
• W2078744527 cites W2023958535 @default.
• W2078744527 cites W2032825252 @default.
• W2078744527 cites W2059290365 @default.
• W2078744527 cites W2072574710 @default.
• W2078744527 cites W2074489152 @default.
• W2078744527 cites W2075149823 @default.
• W2078744527 cites W2078039240 @default.
• W2078744527 cites W2086531765 @default.
• W2078744527 cites W2151277699 @default.
• W2078744527 cites W2152472326 @default.
• W2078744527 doi "https://doi.org/10.1111/j.1749-6632.1988.tb38545.x" @default.
• W2078744527 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2837957" @default.
• W2078744527 hasPublicationYear "1988" @default.
• W2078744527 type Work @default.
• W2078744527 sameAs 2078744527 @default.
• W2078744527 citedByCount "26" @default.
• W2078744527 countsByYear W20787445272014 @default.
• W2078744527 crossrefType "journal-article" @default.
• W2078744527 hasAuthorship W2078744527A5061708161 @default.
• W2078744527 hasAuthorship W2078744527A5064945180 @default.
• W2078744527 hasAuthorship W2078744527A5082695286 @default.
• W2078744527 hasConcept C185592680 @default.
• W2078744527 hasConcept C203014093 @default.
• W2078744527 hasConcept C2776042228 @default.
• W2078744527 hasConcept C2776452501 @default.
• W2078744527 hasConcept C2776685179 @default.
• W2078744527 hasConcept C2776914184 @default.
• W2078744527 hasConcept C71924100 @default.
• W2078744527 hasConcept C8891405 @default.
• W2078744527 hasConceptScore W2078744527C185592680 @default.
• W2078744527 hasConceptScore W2078744527C203014093 @default.
• W2078744527 hasConceptScore W2078744527C2776042228 @default.
• W2078744527 hasConceptScore W2078744527C2776452501 @default.
• W2078744527 hasConceptScore W2078744527C2776685179 @default.
• W2078744527 hasConceptScore W2078744527C2776914184 @default.
• W2078744527 hasConceptScore W2078744527C71924100 @default.
• W2078744527 hasConceptScore W2078744527C8891405 @default.
• W2078744527 hasIssue "1" @default.
• W2078744527 hasLocation W20787445271 @default.
• W2078744527 hasLocation W20787445272 @default.
• W2078744527 hasOpenAccess W2078744527 @default.
• W2078744527 hasPrimaryLocation W20787445271 @default.
• W2078744527 hasRelatedWork W1542903753 @default.
• W2078744527 hasRelatedWork W1896538588 @default.
• W2078744527 hasRelatedWork W1911021899 @default.
• W2078744527 hasRelatedWork W1965950297 @default.
• W2078744527 hasRelatedWork W1992360684 @default.
• W2078744527 hasRelatedWork W2001115002 @default.
• W2078744527 hasRelatedWork W2009019977 @default.
• W2078744527 hasRelatedWork W2033749325 @default.
• W2078744527 hasRelatedWork W2166525518 @default.
• W2078744527 hasRelatedWork W2186461858 @default.
• W2078744527 hasVolume "524" @default.
• W2078744527 isParatext "false" @default.
• W2078744527 isRetracted "false" @default.
• W2078744527 magId "2078744527" @default.
• W2078744527 workType "article" @default.